AI assistant
NextTrip, Inc. — Director's Dealing 2020
Feb 27, 2020
34837_dirs_2020-02-26_6adf7c5f-adc8-450e-b7b5-ea549c4ff4af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SIGMA LABS, INC. (SGLB)
CIK: 0000788611
Period of Report: 2020-01-28
Reporting Person: Battinelli Salvatore F (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-28 | Series E Preferred Stock | $1.03 | A | 16.67 | Acquired | Common Stock (31756) | Direct | |
| 2020-01-28 | Warrants to Purchase Common Stock | $1.13 | A | 24272 | Acquired | 2025-07-28 | Common Stock (24272) | Direct |
Footnotes
F1: Pursuant to a Securities Purchase Agreement between the Company and the Reporting Person, the Reporting Person purchased 16.67 shares of the Company's Series E Preferred Stock (the "Preferred Shares") and warrants to purchase 24,272 shares of the Company's Common Stock for an aggregate purchase price of $25,000 or $1,500 per Preferred Share (the "Stated Value"). Dividends accrue on a monthly basis of 9% per annum and shall increase the Stated Value. The holder shall have the right to convert the Preferred Shares into common shares at a conversion rate determined by dividing the Conversion Amount by $1.03. The Conversion Amount is the sum of the Stated Value (including as a result of accrued dividends) plus the amount of any dividend that, but for the conversion, would have accrued at the dividend rate for the three year period commencing January 28, 2020. The Preferred Shares have no expiration date.
F2: Represents the maximum amount of common shares issuable upon conversion as described in footnote 1.